Innovative Journal of Pediatrics
The Scientific Journal of Growth & Development Research Center
e-ISSN 3117-5341
Image Credit:Inn J Pediatr
Outline
Whole Lung Lavage of Nine Children with Pulmonary Alveolar Proteinosis: Experience in a Tertiary Lung Center
Authors
Badiozaman Radpay1, Tahereh Parsa2, Shideh Dabir3,*, Mohammadreza Boloursaz4, Ahmadreza Arbab5, Seyyedahmad Tabatabaei6
Published online:Dec 13, 2012
Article type:Case Report
Received:Mar 03, 2011
Accepted:Feb 22, 2012
How to Cite:Radpay B, Parsa T, Dabir S, Boloursaz M, Arbab A, et al. Whole Lung Lavage of Nine Children with Pulmonary Alveolar Proteinosis: Experience in a Tertiary Lung Center. Inn J Pediatr. 2013;23(1):. doi:
Abstract
Background: Pulmonary alveolar proteinosis (PAP) is a rare disease in children, characterized by intra-alveolar accumulation of large amounts of surfactant proteins, which severely reduce gas exchange. Whole lung lavage (WLL) is the preferred technique for the treatment of severe PAP.
Case Presentation: This report presents nine pediatric cases with advanced PAP who underwent WLL under general anesthesia during a 9 year period. One patient was treated with multiple unilateral WLL without employing cardiopulmonary bypass (CPB) and eight cases were treated by simultaneous lavage of both lungs using partial CPB.
Conclusion: Our experience suggested that partial CPB was useful to support oxygenation during WLL in small children with severe PAP in whom lung separation and selective lavaging of each lung were impracticable.
Highlights
References
- 1.References are available on the PDF.
Copyright
© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
23
Dec
2015
Management of Alveolar Proteinosis by Bronchopulmonary lavage under Extra Corporeal Membrane Oxygenation (ECMO)
Tahereh Parsa,
Ardeshir Tajbakhsh,
Zargham Hossein Ahmadi,
Behrooz Farzanegan,
Alireza Jahangirifard
Parsa T, Tajbakhsh A, Hossein Ahmadi Z, Farzanegan B, Jahangirifard A. Management of Alveolar Proteinosis by Bronchopulmonary lavage under Extra Corporeal Membrane Oxygenation (ECMO). J Cell Mol Anesth. 2016;1(1):e150241. doi: https://doi.org/10.22037/jcma.v1i1.10604
7
Sep
2026
Telemedicine-Based Functional Monitoring in Pulmonary Alveolar Proteinosis: A Pilot Experience of Post-Whole-Lung Lavage Follow-up
Lida Fadaizadeh,
Tahereh Parsa,
Kobra Rafie Badi,
Moein Daneshmand
Fadaizadeh L, Parsa T, Rafie Badi K, Daneshmand M. Telemedicine-Based Functional Monitoring in Pulmonary Alveolar Proteinosis: A Pilot Experience of Post-Whole-Lung Lavage Follow-up. J Cell Mol Anesth. 2026;11(3):e173477. doi: https://doi.org/10.5812/jcma-173477
23
Dec
2015
Exogenous Lipoid Pneumonia: Dramatic Clinical and Radiological Improvement After Multiple Segmental Bronchoalveolar Lavages
Mohammadreza Modaresi,
Minoo Dadkhah,
Sayed Javad Sayedi
Modaresi M, Dadkhah M, Sayedi SJ. Exogenous Lipoid Pneumonia: Dramatic Clinical and Radiological Improvement After Multiple Segmental Bronchoalveolar Lavages. Inn J Pediatr. 2015;25(6):e3172. doi: https://doi.org/10.5812/ijp.3172
7
Aug
2017
Anesthesia for Pediatric Lung Transplantation: Case Presentation and Review of the Literature
Premal M Trivedi,
Erin A Gottlieb,
Emad B Mossad
Trivedi PM, Gottlieb EA, Mossad EB. Anesthesia for Pediatric Lung Transplantation: Case Presentation and Review of the Literature. J Cell Mol Anesth. 2017;2(3):e149551. doi: https://doi.org/10.22037/jcma.v2i3.17688
9
Dec
2020
Successful Treatment of Severe Parainfluenza Pneumonia in a Liver Transplant Recipient with Oral Ribavirin and Intravenous Immunoglobulin
Fereshteh Ghiasvand,
Zahra Ahmadinejad,
Davood Mansouri,
Elham Raisi,
Mohammad Taher,
Samrand Fattah Ghazi
Ghiasvand F, Ahmadinejad Z, Mansouri D, Raisi E, Taher M, et al. Successful Treatment of Severe Parainfluenza Pneumonia in a Liver Transplant Recipient with Oral Ribavirin and Intravenous Immunoglobulin. Arch Clin Infect Dis. 2020;15(6):e100462. doi: https://doi.org/10.5812/archcid.100462
Cited by
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 15
Last Update: 1 week ago
- Scopus by Title (Ref): 0
Last Update: 1 week ago
- CrossRef: 0
Last Update: 5 hours ago
- OpenAlex: 0
Last Update: 8 hours ago
- OpenCitations: 0
Last Update: 5 days ago
Comments
Number of Comments:0